Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation
Clinical trial NCT02218723 · COMPLETED
Trial details
- NCT number
- NCT02218723
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2014-12-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.